Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

QUESTION 1: Do balanced fluids have benefits over 0.9% sodium chloride?

Patel A, Hulton SA.

Arch Dis Child. 2018 Dec;103(12):1178-1180. doi: 10.1136/archdischild-2018-315782. Epub 2018 Sep 27. No abstract available.

PMID:
30262508
2.

Primary Hyperoxaluria Type 2.

Rumsby G, Hulton SA.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2008 Dec 2 [updated 2017 Dec 21].

3.

Worldwide view of nephropathic cystinosis: results from a survey from 30 countries.

Bertholet-Thomas A, Berthiller J, Tasic V, Kassai B, Otukesh H, Greco M, Ehrich J, de Paula Bernardes R, Deschênes G, Hulton SA, Fischbach M, Soulami K, Saeed B, Valavi E, Cobenas CJ, Hacihamdioglu B, Weiler G, Cochat P, Bacchetta J.

BMC Nephrol. 2017 Jul 3;18(1):210. doi: 10.1186/s12882-017-0633-3.

4.

Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.

Talati JJ, Hulton SA, Garrelfs SF, Aziz W, Rao S, Memon A, Nazir Z, Biyabani R, Qazi S, Azam I, Khan AH, Ahmed J, Jafri L, Zeeshan M.

Urolithiasis. 2018 Apr;46(2):187-195. doi: 10.1007/s00240-017-0996-8. Epub 2017 Jun 28. Review.

PMID:
28660284
5.

A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.

Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, Cochat P.

Pediatr Nephrol. 2017 May;32(5):781-790. doi: 10.1007/s00467-016-3553-8. Epub 2016 Dec 6.

PMID:
27924398
6.

The primary hyperoxalurias: A practical approach to diagnosis and treatment.

Hulton SA.

Int J Surg. 2016 Dec;36(Pt D):649-654. doi: 10.1016/j.ijsu.2016.10.039. Epub 2016 Nov 1. Review.

7.

Combined liver and kidney transplantation in children: analysis of renal graft outcome.

Ranawaka R, Lloyd C, McKiernan PJ, Hulton SA, Sharif K, Milford DV.

Pediatr Nephrol. 2016 Sep;31(9):1539-43. doi: 10.1007/s00467-016-3396-3. Epub 2016 Apr 22.

PMID:
27105881
8.

Coercion and choice in parent-child live kidney donation.

Burnell P, Hulton SA, Draper H.

J Med Ethics. 2015 Apr;41(4):304-9. doi: 10.1136/medethics-2013-101988. Epub 2014 Nov 6.

PMID:
25378550
9.

Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type.

Mandrile G, van Woerden CS, Berchialla P, Beck BB, Acquaviva Bourdain C, Hulton SA, Rumsby G; OxalEurope Consortium.

Kidney Int. 2014 Dec;86(6):1197-204. doi: 10.1038/ki.2014.222. Epub 2014 Jul 2.

10.

Adherence in paediatric renal failure and dialysis: an ethical analysis of nurses' attitudes and reported practice.

Mellor JS, Hulton SA, Draper H.

J Med Ethics. 2015 Feb;41(2):151-6. doi: 10.1136/medethics-2013-101659. Epub 2014 Jan 10.

PMID:
24413583
11.

Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.

Cross JH, Arora R, Heckemann RA, Gunny R, Chong K, Carr L, Baldeweg T, Differ AM, Lench N, Varadkar S, Sirimanna T, Wassmer E, Hulton SA, Ognjanovic M, Ramesh V, Feather S, Kleta R, Hammers A, Bockenhauer D.

Dev Med Child Neurol. 2013 Sep;55(9):846-56. doi: 10.1111/dmcn.12171.

12.

Effect on early graft function of high-dose desmopressin in transplant recipients with bleeding disorders.

Tramma D, O'Brien C, Hulton SA.

Saudi J Kidney Dis Transpl. 2013 Mar;24(2):364-5. No abstract available.

13.

Extracorporal shock wave lithotripsy in the management of stones in children with oxalosis--still the first choice?

Al-Abadi E, Hulton SA.

Pediatr Nephrol. 2013 Jul;28(7):1085-9. doi: 10.1007/s00467-013-2424-9. Epub 2013 Feb 9.

PMID:
23397522
14.

17q12 microdeletion syndrome: three patients illustrating the phenotypic spectrum.

Dixit A, Patel C, Harrison R, Jarvis J, Hulton S, Smith N, Yates K, Silcock L, McMullan DJ, Suri M.

Am J Med Genet A. 2012 Sep;158A(9):2317-21. doi: 10.1002/ajmg.a.35520. Epub 2012 Aug 6.

PMID:
22887843
15.

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.

Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS; OxalEurope.

Nephrol Dial Transplant. 2012 May;27(5):1729-36. doi: 10.1093/ndt/gfs078.

16.

Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy.

Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Cerkauskiene R, Schaefer F, Verrina E, Jager KJ, Cochat P; European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry.

Clin J Am Soc Nephrol. 2012 Mar;7(3):458-65. doi: 10.2215/CJN.07430711. Epub 2012 Jan 5.

17.

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D.

Nephrol Dial Transplant. 2011 Nov;26(11):3609-15. doi: 10.1093/ndt/gfr107. Epub 2011 Apr 2.

PMID:
21460356
18.

Renal transplantation in a boy with methylmalonic acidaemia.

Clothier JC, Chakrapani A, Preece MA, McKiernan P, Gupta R, Macdonald A, Hulton SA.

J Inherit Metab Dis. 2011 Jun;34(3):695-700. doi: 10.1007/s10545-011-9303-y. Epub 2011 Mar 17.

PMID:
21416195
19.

Altered electroretinograms in patients with KCNJ10 mutations and EAST syndrome.

Thompson DA, Feather S, Stanescu HC, Freudenthal B, Zdebik AA, Warth R, Ognjanovic M, Hulton SA, Wassmer E, van't Hoff W, Russell-Eggitt I, Dobbie A, Sheridan E, Kleta R, Bockenhauer D.

J Physiol. 2011 Apr 1;589(Pt 7):1681-9. doi: 10.1113/jphysiol.2010.198531. Epub 2011 Feb 7.

20.

Autosomal dominant polycystic kidney disease (ADPKD) associated with steroid-sensitive nephrotic syndrome in childhood.

Siomou E, Jarvis J, Hulton SA.

Pediatr Nephrol. 2011 Apr;26(4):643-4. doi: 10.1007/s00467-010-1710-z. Epub 2010 Nov 30. No abstract available.

PMID:
21116827
21.

KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function.

Reichold M, Zdebik AA, Lieberer E, Rapedius M, Schmidt K, Bandulik S, Sterner C, Tegtmeier I, Penton D, Baukrowitz T, Hulton SA, Witzgall R, Ben-Zeev B, Howie AJ, Kleta R, Bockenhauer D, Warth R.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14490-5. doi: 10.1073/pnas.1003072107. Epub 2010 Jul 22.

22.

Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration.

Perera MT, Sharif K, Lloyd C, Foster K, Hulton SA, Mirza DF, McKiernan PJ.

Nephrol Dial Transplant. 2011 Jan;26(1):354-9. doi: 10.1093/ndt/gfq353. Epub 2010 Jun 23.

PMID:
20573805
23.

Primary cultures of renal proximal tubule cells derived from individuals with primary hyperoxaluria.

Price KL, Hulton SA, van't Hoff WG, Masters JR, Rumsby G.

Urol Res. 2009 Jun;37(3):127-32. doi: 10.1007/s00240-009-0185-5. Epub 2009 Mar 13.

PMID:
19283374
24.

Renal tubular function in children with tyrosinaemia type I treated with nitisinone.

Santra S, Preece MA, Hulton SA, McKiernan PJ.

J Inherit Metab Dis. 2008 Jun;31(3):399-402. doi: 10.1007/s10545-008-0817-x. Epub 2008 May 23.

PMID:
18509744
25.

Primary hyperoxaluria.

Johnson SA, Hulton SA.

Saudi J Kidney Dis Transpl. 2004 Jan-Mar;15(1):41-9. No abstract available.

26.

End-stage renal failure in adolescence with Sjögren's syndrome autoantibodies SSA and SSB.

Johnson S, Hulton SA, Brundler MA, Moss C, Huissoon A, Taylor CM.

Pediatr Nephrol. 2007 Oct;22(10):1793-7. Epub 2007 Jul 17.

PMID:
17636342
27.

Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1.

Nissel R, Latta K, Gagnadoux MF, Kelly D, Hulton S, Kemper MJ, Ruder H, Söderdahl G, Otte JB, Cochat P, Roquet O, Jamieson NV, Haffner D.

Transplantation. 2006 Jul 15;82(1):48-54.

PMID:
16861941
28.

Antenatal diagnosis of fetal renal calculus.

Rhodes C, Churchill D, Hulton SA.

Ultrasound Obstet Gynecol. 2005 May;25(5):517-8.

29.

Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.

Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM.

Nephrol Dial Transplant. 2004 Nov;19(11):2769-77. Epub 2004 Sep 22.

PMID:
15385635
30.

Increasing the use of orphan drugs in clinical practice.

Hulton SA, Greener M.

Hosp Med. 2004 Jul;65(7):400-3. Review.

PMID:
15287343
31.

Urinary L-lactate excretion is increased in renal Fanconi syndrome.

Thirumurugan A, Thewles A, Gilbert RD, Hulton SA, Milford DV, Lote CJ, Taylor CM.

Nephrol Dial Transplant. 2004 Jul;19(7):1767-73. Epub 2004 May 5.

PMID:
15128879
32.
33.

Lip hypertrophy secondary to cyclosporin treatment.

Cansick JC, Hulton SA.

Pediatr Nephrol. 2003 Jul;18(7):710-1. Epub 2003 May 16.

PMID:
12750983
34.

Polarization of superfluid turbulence.

Barenghi CF, Hulton S, Samuels DC.

Phys Rev Lett. 2002 Dec 30;89(27):275301. Epub 2002 Dec 16.

PMID:
12513214
35.

Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss.

Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, Giersch AB, Morton CC, Axon PR, Akil I, Al-Sabban EA, Baguley DM, Bianca S, Bakkaloglu A, Bircan Z, Chauveau D, Clermont MJ, Guala A, Hulton SA, Kroes H, Li Volti G, Mir S, Mocan H, Nayir A, Ozen S, Rodriguez Soriano J, Sanjad SA, Tasic V, Taylor CM, Topaloglu R, Smith AN, Karet FE.

J Med Genet. 2002 Nov;39(11):796-803.

36.

Primary hyperoxaluria type 2 in children.

Johnson SA, Rumsby G, Cregeen D, Hulton SA.

Pediatr Nephrol. 2002 Aug;17(8):597-601. Epub 2002 Jun 6.

PMID:
12185464
37.

Hypertension: a cause of growth impairment.

Deshpande PV, Gilbert RD, Williams J, Hulton SA, Milford DV.

J Hum Hypertens. 2002 May;16(5):363-6.

38.

Cyclosporin-related nephrotoxicity in children with nephrotic syndrome.

Ganesan V, Milford DV, Taylor CM, Hulton SA, Parvaresh S, Ramani P.

Pediatr Nephrol. 2002 Mar;17(3):225-6; author reply 227. No abstract available.

PMID:
11956868
39.

Evaluation of urinary tract calculi in children.

Hulton SA.

Arch Dis Child. 2001 Apr;84(4):320-3. Review. No abstract available.

40.

Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.

Ellis SR, Hulton SA, McKiernan PJ, de Ville de Goyet J, Kelly DA.

Nephrol Dial Transplant. 2001 Feb;16(2):348-54.

PMID:
11158411
41.

Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing.

Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, Scherer SW, Karet FE.

Nat Genet. 2000 Sep;26(1):71-5.

PMID:
10973252
42.

Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34.

Karet FE, Finberg KE, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Medina JF, Lifton RP.

Am J Hum Genet. 1999 Dec;65(6):1656-65.

43.

Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness.

Karet FE, Finberg KE, Nelson RD, Nayir A, Mocan H, Sanjad SA, Rodriguez-Soriano J, Santos F, Cremers CW, Di Pietro A, Hoffbrand BI, Winiarski J, Bakkaloglu A, Ozen S, Dusunsel R, Goodyer P, Hulton SA, Wu DK, Skvorak AB, Morton CC, Cunningham MJ, Jha V, Lifton RP.

Nat Genet. 1999 Jan;21(1):84-90.

PMID:
9916796
44.

Vincristine and focal segmental sclerosis: do we need a multicentre trial?

Goonasekera CD, Koziell AB, Hulton SA, Dillon MJ.

Pediatr Nephrol. 1998 May;12(4):284-9.

PMID:
9655358
45.

Care in the use of ibuprofen as an antipyretic in children.

Moghal NE, Hulton SA, Milford DV.

Clin Nephrol. 1998 May;49(5):293-5.

PMID:
9617491
46.

Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.

Karet FE, Gainza FJ, Györy AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, Bakkaloglu A, Ozen S, Cunningham MJ, di Pietro A, Walker WG, Lifton RP.

Proc Natl Acad Sci U S A. 1998 May 26;95(11):6337-42.

47.
48.

The prevalence and treatment of end-stage renal disease in an Asian child population.

Moghal NE, Milford DV, Hulton SA, Taylor CM.

Nephrol Dial Transplant. 1997 Dec;12(12):2517-20.

PMID:
9430845
49.

Circulating interleukin 2 receptor (IL2R) in nephrotic syndrome.

Hulton SA, Neuhaus TJ, Callard RE, Dillon MJ, Barratt TM.

Kidney Int Suppl. 1997 Mar;58:S83-4. Review. No abstract available.

PMID:
9067952
50.

A case of neonatal Bartter's syndrome.

Wong W, Hulton SA, Taylor CM, Raafat F, Lote CJ, Lindop G.

Pediatr Nephrol. 1996 Aug;10(4):414-8.

PMID:
8865234

Supplemental Content

Loading ...
Support Center